Citadel Advisors »

Adial Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $76k 30k 2.56

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Adial Pharmaceuticals

Jane Street
Citadel Advisors
Intl Fcstone
UBS Group
Geode Capital Management
China Universal Asset Management
Vanguard Fiduciary Trust
Vanguard Capital Management
Manchester Capital Management
Tower Research Capital
BlackRock
Raffa Wealth Management
Morgan Stanley
SBI Securities
Wells Fargo & Company

View all funds holding Adial Pharmaceuticals